Evolving Patterns of EBV ‐Associated PTLD After Allogeneic Stem Cell Transplantation: Frequency, Characteristics and Outcomes in a Multicenter GETH ‐ TC Study

Documenti analoghi

• Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH ‐ TC Pediatric Group
  di: Luisa Sisinni, et al.
  Pubblicazione: (2026)
• Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH‐TC
  di: Estela Giménez, et al.
  Pubblicazione: (2026)
• Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post‐transplant cyclophosphamide era: A GETH ‐ TC study
  di: Marta Peña, et al.
  Pubblicazione: (2026)
• Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study
  di: Peña, M., et al.
  Pubblicazione: (2026)
• Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
  di: Estela Giménez, et al.
  Pubblicazione: (2025)